WuXi Biologics (Cayman) Inc.
General ticker "WXIBF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.2B (TTM average)
WuXi Biologics (Cayman) Inc. follows the US Stock Market performance with the rate: 20.9%.
Estimated limits based on current volatility of 1.0%: low 4.33$, high 4.44$
Short-term WXIBF quotes
Long-term WXIBF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CNY17,034.26MM | CNY18,675.37MM | CNY21,227.71MM |
| Operating Expenses | CNY12,584.06MM | CNY13,701.57MM | CNY14,752.73MM |
| Operating Income | CNY4,450.20MM | CNY4,973.80MM | CNY6,474.98MM |
| Non-Operating Income | CNY-276.39MM | CNY-139.41MM | CNY594.66MM |
| Interest Expense | CNY158.49MM | CNY157.59MM | CNY139.37MM |
| R&D Expense | CNY792.58MM | CNY766.44MM | CNY831.35MM |
| Income(Loss) | CNY4,173.80MM | CNY4,834.40MM | CNY7,069.64MM |
| Taxes | CNY603.18MM | CNY889.03MM | CNY1,484.36MM |
| Net Income(Loss)* | CNY3,399.73MM | CNY3,356.08MM | CNY4,781.68MM |
| Stockholders Equity | CNY40,331.60MM | CNY41,819.21MM | CNY47,272.54MM |
| Inventory | CNY1,765.75MM | CNY1,521.67MM | CNY1,440.85MM |
| Assets | CNY56,575.73MM | CNY56,977.43MM | CNY63,728.91MM |
| Operating Cash Flow | CNY4,667.71MM | CNY5,217.26MM | CNY6,388.97MM |
| Capital expenditure | CNY4,230.51MM | CNY3,929.62MM | CNY3,590.02MM |
| Investing Cash Flow | CNY-3,228.27MM | CNY-3,941.71MM | CNY-3,383.74MM |
| Financing Cash Flow | CNY1,961.16MM | CNY-2,750.19MM | CNY-1,952.68MM |
| Earnings Per Share** | CNY0.82 | CNY0.82 | CNY1.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.